Cannabis can provide patients benefits for pain and symptom management, improve their functionality, and enhance their well-being. Yet restrictive medical cannabis programs can limit these potential benefits. This article draws on four years of research into Minnesota’s medical cannabis program—one of the most restrictive in the United States—including in-depth interviews with patients and a survey of health care professionals. Drawing on the new materialist concepts of Deleuze and Guattari, this article analyzes (a) the benefits patients in Minnesota’s medical cannabis program derive from cannabis, (b) how program restrictions mediate access to cannabis and its derived benefits, and (c) some key ways in which medical and criminal justice institutional authorities are reconfigured around medical cannabis. I show how the imperative to authoritatively govern “dangerous drugs” persists in consequential ways as the War on Drugs shifts toward a medicalized, criminalized, and commercial-legalized mixed regime.

中文翻译：

---

痛苦的受试者，渴望缓解：在医用大麻项目中体验和控制疼痛


大麻可以为患者带来缓解疼痛和症状的益处，改善他们的功能，并增强他们的健康。然而，限制性医用大麻计划可能会限制这些潜在的好处。本文借鉴了对明尼苏达州医用大麻计划（美国限制最严格的计划之一）的四年研究成果，包括对患者的深入访谈和对医疗保健专业人员的调查。本文借鉴德勒兹和瓜塔里的新唯物主义概念，分析了（a）明尼苏达州医用大麻计划中的患者从大麻中获得的好处，（b）计划限制如何调节获得大麻及其衍生的好处，以及（c）一些关键因素围绕医用大麻重新配置医疗和刑事司法机构当局的方式。我展示了随着毒品战争转向医疗化、犯罪化和商业合法化的混合政权，对“危险毒品”进行权威管理的必要性如何以相应的方式持续存在。